Bruker Net Profit Margin 2010-2023 | BRKR
Current and historical net profit margin for Bruker (BRKR) from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue. Bruker net profit margin for the three months ending December 31, 2023 was .
| Bruker Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2023-12-31 |
$2.96B |
$0.43B |
14.44% |
| 2023-09-30 |
$2.82B |
$0.32B |
11.32% |
| 2023-06-30 |
$2.71B |
$0.32B |
11.75% |
| 2023-03-31 |
$2.62B |
$0.31B |
11.91% |
| 2022-12-31 |
$2.53B |
$0.30B |
11.74% |
| 2022-09-30 |
$2.51B |
$0.28B |
11.02% |
| 2022-06-30 |
$2.48B |
$0.28B |
11.11% |
| 2022-03-31 |
$2.46B |
$0.28B |
11.51% |
| 2021-12-31 |
$2.42B |
$0.28B |
11.50% |
| 2021-09-30 |
$2.36B |
$0.27B |
11.47% |
| 2021-06-30 |
$2.27B |
$0.24B |
10.51% |
| 2021-03-31 |
$2.12B |
$0.20B |
9.63% |
| 2020-12-31 |
$1.99B |
$0.16B |
7.95% |
| 2020-09-30 |
$1.96B |
$0.16B |
8.06% |
| 2020-06-30 |
$1.97B |
$0.17B |
8.38% |
| 2020-03-31 |
$2.04B |
$0.18B |
8.75% |
| 2019-12-31 |
$2.07B |
$0.20B |
9.56% |
| 2019-09-30 |
$2.03B |
$0.21B |
10.22% |
| 2019-06-30 |
$1.97B |
$0.19B |
9.58% |
| 2019-03-31 |
$1.93B |
$0.18B |
9.50% |
| 2018-12-31 |
$1.90B |
$0.18B |
9.44% |
| 2018-09-30 |
$1.87B |
$0.10B |
5.23% |
| 2018-06-30 |
$1.84B |
$0.09B |
4.99% |
| 2018-03-31 |
$1.81B |
$0.08B |
4.63% |
| 2017-12-31 |
$1.77B |
$0.08B |
4.47% |
| 2017-09-30 |
$1.71B |
$0.15B |
8.85% |
| 2017-06-30 |
$1.66B |
$0.16B |
9.68% |
| 2017-03-31 |
$1.62B |
$0.15B |
9.44% |
| 2016-12-31 |
$1.61B |
$0.16B |
9.62% |
| 2016-09-30 |
$1.62B |
$0.15B |
9.08% |
| 2016-06-30 |
$1.62B |
$0.11B |
6.91% |
| 2016-03-31 |
$1.65B |
$0.12B |
7.23% |
| 2015-12-31 |
$1.62B |
$0.10B |
6.28% |
| 2015-09-30 |
$1.65B |
$0.07B |
4.05% |
| 2015-06-30 |
$1.68B |
$0.06B |
3.64% |
| 2015-03-31 |
$1.74B |
$0.06B |
3.16% |
| 2014-12-31 |
$1.81B |
$0.06B |
3.15% |
| 2014-09-30 |
$1.85B |
$0.07B |
3.56% |
| 2014-06-30 |
$1.87B |
$0.08B |
4.11% |
| 2014-03-31 |
$1.87B |
$0.08B |
4.49% |
| 2013-12-31 |
$1.84B |
$0.08B |
4.35% |
| 2013-09-30 |
$1.80B |
$0.06B |
3.22% |
| 2013-06-30 |
$1.81B |
$0.08B |
4.47% |
| 2013-03-31 |
$1.78B |
$0.07B |
3.82% |
| 2012-12-31 |
$1.79B |
$0.08B |
4.35% |
| 2012-09-30 |
$1.75B |
$0.10B |
5.94% |
| 2012-06-30 |
$1.72B |
$0.08B |
4.88% |
| 2012-03-31 |
$1.70B |
$0.10B |
5.65% |
| 2011-12-31 |
$1.65B |
$0.09B |
5.57% |
| 2011-09-30 |
$1.59B |
$0.08B |
5.15% |
| 2011-06-30 |
$1.48B |
$0.09B |
6.00% |
| 2011-03-31 |
$1.38B |
$0.09B |
6.50% |
| 2010-12-31 |
$1.31B |
$0.10B |
7.28% |
| 2010-09-30 |
$1.26B |
$0.11B |
8.76% |
| 2010-06-30 |
$1.21B |
$0.10B |
8.18% |
| 2010-03-31 |
$1.16B |
$0.09B |
7.66% |
| 2009-12-31 |
$1.12B |
$0.08B |
7.26% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$11.486B |
$2.965B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
